Assistive Technology for Disability: Devices, Tools, and Access Programs
Assistive technology spans an enormous range — from a $3 rubber pencil grip to a $50,000 power wheelchair with tilt-in-space seating — and understanding how these tools are classified, funded, and obtained matters enormously to the people who need them. This page covers the major categories of assistive technology, the regulatory and funding frameworks that govern access, and the practical boundaries that determine which device path applies to a given situation.
Definition and scope
The federal definition lives in the Assistive Technology Act of 1998 (reauthorized in 2004 as the AT Act, Public Law 108-364): assistive technology is any item, piece of equipment, or product system — whether acquired commercially, modified, or customized — that is used to increase, maintain, or improve the functional capabilities of individuals with disabilities. That definition is deliberately broad, and deliberately so. A screen reader software package and a bath transfer bench are both assistive technology under that standard.
The National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) classifies assistive technology into two dimensions that cut across every device type:
- Low-tech vs. high-tech: Low-tech AT requires no power source and minimal training — a cane, a weighted spoon, a magnification sheet. High-tech AT involves electronics, software, or power systems — speech-generating devices, cochlear implants, eye-gaze communication boards driven by infrared cameras.
- No-tech accommodations (sometimes treated as a third category): environmental modifications like grab bars, ramp installations, or furniture repositioning that serve the same functional purpose without constituting a discrete device.
The Rehabilitation Engineering and Assistive Technology Society of North America (RESNA) maintains the professional credentialing standards for AT practitioners, including the Assistive Technology Professional (ATP) and Seating and Mobility Specialist (SMS) certifications — the two credentials most relevant when complex or high-cost devices are being prescribed.
How it works
Assistive technology reaches users through one of four primary pathways, each governed by different eligibility rules and funding streams:
-
Medicaid waiver programs: Durable medical equipment (DME) categories under Medicaid cover power wheelchairs, augmentative and alternative communication (AAC) devices, hearing aids (in states that include them), and orthotics/prosthetics. Coverage criteria vary by state, but the federal baseline is established under 42 CFR Part 440. A physician or licensed therapist must document medical necessity, and prior authorization is standard for items above a cost threshold.
-
State Vocational Rehabilitation (VR) programs: Under Title I of the Rehabilitation Act of 1973, state VR agencies fund AT when it is part of an Individualized Plan for Employment (IPE). This pathway is employment-oriented — AT funded here must relate to job acquisition or retention. Screen magnification software, ergonomic workstation equipment, and portable communication devices are common VR-funded items.
-
AT Act state programs: The 2004 AT Act requires every state to operate an AT program offering device demonstrations, short-term loans, and device reutilization (used equipment exchange). These programs do not fund purchases directly, but they provide the trial period that helps users verify device fit before committing to a costly acquisition. The AT3 Center, funded by the Administration for Community Living (ACL), coordinates this national network.
-
Education funding under IDEA: The Individuals with Disabilities Education Act (IDEA) requires that assistive technology be considered for every student with a disability during IEP development. If the IEP team determines AT is necessary for the child to receive a free appropriate public education (FAPE), the school district is obligated to provide it at no cost to the family. This applies to software, hardware, and devices — including AAC systems that may cost upward of $8,000.
Common scenarios
Three situations illustrate how AT classification decisions play out in practice.
Communication disability: A child with cerebral palsy who cannot produce intelligible speech may receive an AAC device — ranging from a low-tech picture exchange communication system (PECS) board to a high-tech eye-gaze device like a Tobii Dynavox. The American Speech-Language-Hearing Association (ASHA) has published practice guidelines establishing that AAC devices are medical and educational necessities, not optional supplements. Funding often requires a speech-language pathology evaluation, a feature-matching trial, and a letter of medical necessity submitted to Medicaid or private insurer.
Mobility disability: A person with a spinal cord injury requiring a custom power wheelchair faces a process that typically involves a certified ATP, a physical or occupational therapist with seating credentials, and a supplier enrolled in Medicare or Medicaid. Medicare Part B covers power wheelchairs under the complex rehabilitative technology (CRT) category, which has stricter documentation requirements than standard DME — including face-to-face physician evaluation and detailed written orders.
Vision disability: Screen reader software (such as JAWS or NVDA), refreshable braille displays, and optical character recognition tools fall under the broad AT umbrella. Web and digital accessibility for disabilities intersects here, since digital AT tools only function when the platforms they operate on comply with WCAG 2.1 accessibility standards — a legal obligation under Section 508 and increasingly under ADA Title III litigation.
Decision boundaries
Knowing which pathway to pursue — and which device category applies — involves distinguishing between overlapping frameworks. The regulatory context for disability shapes these boundaries significantly.
The key distinctions to hold:
-
Medical necessity vs. educational necessity: A device may qualify under both IDEA and Medicaid, but the funding responsibility differs. Under a coordination-of-benefits principle, Medicaid cannot be billed for items that IDEA requires the school district to provide. The CMS guidance on Medicaid and IDEA coordination clarifies that Medicaid may pay for health-related AT services when a student is Medicaid-eligible, but the school district retains the primary FAPE obligation.
-
Complex rehabilitative technology (CRT) vs. standard DME: CRT devices — defined under the Ensuring Continuity of Care Act (H.R. 3229) framework — require individually configured components and a team-based evaluation. Standard DME (a basic manual wheelchair, a hospital bed) moves through a simpler prior authorization process. Applying a DME pathway to a CRT need frequently results in denial or provision of a clinically inadequate device.
-
No-cost provisions vs. cost-sharing: Under IDEA, AT provided as part of FAPE carries zero cost to families. Under Medicaid, cost-sharing obligations depend on state plan rules and whether the individual is below income thresholds. VR-funded AT may require a financial needs assessment, depending on state policy.
The broader disability support landscape encompasses much more than technology — housing, employment, income support, and healthcare coverage each intersect with AT access in ways that can accelerate or stall device acquisition. AT funding decisions rarely exist in isolation from those surrounding systems.
References
- Assistive Technology Act of 2004, Public Law 108-364 (GovInfo)
- National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) — ACL
- Rehabilitation Engineering and Assistive Technology Society of North America (RESNA)
- Individuals with Disabilities Education Act (IDEA) — U.S. Department of Education
- 42 CFR Part 440 — Medicaid Services (eCFR)
- American Speech-Language-Hearing Association (ASHA) — AAC
- Medicare Durable Medical Equipment Coverage — Medicare.gov
- AT3 Center — Administration for Community Living
- CMS Early and Periodic Screening, Diagnostic, and Treatment (EPSDT)